# Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis

> **NCT00279162** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 160 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Calcipotriene/betamethasone gel and ointment

## Key facts

- **NCT ID:** NCT00279162
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00279162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00279162, "Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00279162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*